Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud Aljurf

Showing results (161-170 of 403) with videos related to

Pageof 41
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]Navneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Journal of Hematology & Oncology|April 2, 2021
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Mohamed Houhou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Transplantation and Cellular Therapy|September 22, 2024
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular TherapyRaheel Iftikhar, Zachariah DeFilipp, Amy E DeZern, et al.
Bone Marrow Transplantation|April 1, 2026
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysisJean El Cheikh, Ali Tarhini, Ali Bazarbachi, et al.
Blood|October 23, 2013
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experienceRégis Peffault de Latour, Raphael Porcher, Jean-Hugues Dalle, et al.
Transplantation and Cellular Therapy|December 5, 2025
Low-Dose Post-Transplant Cyclophosphamide in Haploidentical Stem Cell Transplantation: A Systematic ReviewAreez Shafqat, Omar Ahmad, Mohammed H Omer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa regionAli Bazarbachi, Hamdy A Azim, Hussain Alizadeh, et al.
Haematologica|August 24, 2019
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationKazimierz Halaburda, Myriam Labopin, Audrey Mailhol, et al.
Cancer|September 16, 2022
Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMTArnon Nagler, Myriam Labopin, Mutlu Arat, et al.
Pageof 41

Showing results (161-170 of 403) with videos related to

Sort By:
Pageof 41
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]Navneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Journal of Hematology & Oncology|April 2, 2021
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Mohamed Houhou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Transplantation and Cellular Therapy|September 22, 2024
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular TherapyRaheel Iftikhar, Zachariah DeFilipp, Amy E DeZern, et al.
Bone Marrow Transplantation|April 1, 2026
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysisJean El Cheikh, Ali Tarhini, Ali Bazarbachi, et al.
Blood|October 23, 2013
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experienceRégis Peffault de Latour, Raphael Porcher, Jean-Hugues Dalle, et al.
Transplantation and Cellular Therapy|December 5, 2025
Low-Dose Post-Transplant Cyclophosphamide in Haploidentical Stem Cell Transplantation: A Systematic ReviewAreez Shafqat, Omar Ahmad, Mohammed H Omer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa regionAli Bazarbachi, Hamdy A Azim, Hussain Alizadeh, et al.
Haematologica|August 24, 2019
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationKazimierz Halaburda, Myriam Labopin, Audrey Mailhol, et al.
Cancer|September 16, 2022
Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMTArnon Nagler, Myriam Labopin, Mutlu Arat, et al.
Pageof 41